The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcome.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 25171377)

Published in Urol Int on August 27, 2014

Authors

M Racioppi1, L Salmaso, C Brombin, R Arboretti, D D'Agostino, R Colombo, V Serretta, M Brausi, G Casetta, P Gontero, R Hurle, R Tenaglia, V Altieri, R Bartoletti, M Maffezzini, S Siracusano, G Morgia, P F Bassi

Author Affiliations

1: Department of Urology, Catholic University of the Sacred Heart, Rome, Italy.

Articles by these authors

Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation (1999) 2.55

Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology (2007) 2.15

Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol (2007) 1.98

Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med (1998) 1.97

Surgical resection for intractable epilepsy in "double cortex" syndrome yields inadequate results. Epilepsia (2001) 1.62

Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers. Clin Cancer Res (2000) 1.60

The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself. Free Radic Biol Med (2001) 1.60

Penile length is normal in most men seeking penile lengthening procedures. Int J Impot Res (2002) 1.53

S-glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med (2004) 1.53

Abnormal fecal flora in a patient with short bowel syndrome. An in vitro study on effect of pH on D-lactic acid production. Dig Dis Sci (1996) 1.47

Video laparoscopic excision of a seminal vesicle cyst associated with ipsilateral renal agenesis. J Urol (1995) 1.45

Focal therapy in prostate cancer-report from a consensus panel. J Endourol (2010) 1.43

Neurilemmoma of the ciliary body: report of a case. Br J Ophthalmol (1983) 1.41

Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction. J Urol (2008) 1.39

The hyperspectral irradiometer, a new instrument for long-term and unattended field spectroscopy measurements. Rev Sci Instrum (2011) 1.38

Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation (1997) 1.38

Reversible S-glutathionylation of Cys 374 regulates actin filament formation by inducing structural changes in the actin molecule. Free Radic Biol Med (2003) 1.34

Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest (1994) 1.28

Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic Biol Med (2002) 1.27

Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group. J Clin Oncol (2001) 1.27

Bladder pheochromocytoma: a 3-year follow-up after transurethral resection (TURB). Urol Int (2000) 1.24

Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology (2004) 1.22

Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic Biol Med (2001) 1.20

Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trial. J Urol (2001) 1.18

Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. J Urol (1993) 1.18

Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management. Int J Clin Pract (2008) 1.18

Low dose bacillus Calmette-Guerin for carcinoma in situ of the bladder: long-term results. J Urol (2000) 1.17

Decreased neonatal dietary fat absorption and T cell cytotoxicity in pancreatic lipase-related protein 2-deficient mice. J Biol Chem (1998) 1.17

Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach. J Urol (2001) 1.16

Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. Eur Urol (1999) 1.14

Quantitative measures of spasticity in post-stroke patients. Clin Neurophysiol (2000) 1.14

Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol (2004) 1.13

Quality control of radical prostatectomy: a feasibility study. Eur J Cancer (2001) 1.13

AMS three-piece inflatable implants for erectile dysfunction: a long-term multi-institutional study in 200 consecutive patients. Eur Urol (2000) 1.12

European larch phenology in the Alps: can we grasp the role of ecological factors by combining field observations and inverse modelling? Int J Biometeorol (2008) 1.10

Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance. Lab Invest (1999) 1.10

Does isoniazid reduce side effects of intravesical bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of European Organization for Research and Treatment of Cancer Protocol 30911. J Urol (1997) 1.10

Clear cell sarcoma of the kidney with invasion of the inferior vena cava. Urol Int (2003) 1.07

galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas. Int J Cancer (1999) 1.06

S-NO-actin: S-nitrosylation kinetics and the effect on isolated vascular smooth muscle. J Muscle Res Cell Motil (2000) 1.06

A preoperative clinical prognostic model for non-metastatic renal cell carcinoma. BJU Int (2003) 1.05

Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol (2006) 1.04

Immunohistochemical detection of estrogen and progesterone receptors in the normal urinary bladder and in pseudomembranous trigonitis. J Endocrinol Invest (1992) 1.04

Microdeletions in interval 6 of the Y chromosome detected by STS-PCR in 6 of 33 patients with idiopathic oligo- or azoospermia. Cytogenet Cell Genet (1996) 1.03

Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res (1998) 1.03

Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study. BJU Int (2003) 1.03

Value of current chemotherapy and surgery in advanced and metastatic bladder cancer. Urol Int (2012) 1.02

Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol (2000) 1.01

Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br J Clin Pharmacol (2001) 1.01

Short- and long-term reproducibility of time and frequency domain heart rate variability measurements in normal subjects. Cardiovasc Res (1996) 0.99

C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron (2002) 0.97

Differential diagnosis of Crohn's disease of the colon from ulcerative colitis: ultrastructure study with the scanning electron microscope. Int J Tissue React (1986) 0.97

Evaluation of intra-muscular EMG signal decomposition algorithms. J Electromyogr Kinesiol (2001) 0.97

Distal urethral reconstruction of the glans for penile carcinoma: results of a novel technique at 1-year of followup. J Urol (2007) 0.96

Decreased heart rate variability in amyotrophic lateral sclerosis. Muscle Nerve (1995) 0.96

Prolonged oxidative stress on actin. Arch Biochem Biophys (1997) 0.95

Childhood cancer registry of the Province of Torino, Italy. Survival, incidence, and mortality over 20 years. Cancer (1992) 0.95

14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up. J Chemother (2009) 0.94

Osmotically induced proton extrusion from carrot cells in suspension culture. Plant Physiol (1987) 0.94

Mitochondrial dysfunction associated with cardiac ischemia/reperfusion can be attenuated by oxygen tension control. Role of oxygen-free radicals and cardiolipin. Biochim Biophys Acta (2005) 0.93

Testing marginal homogeneity against stochastic order in multivariate ordinal data. Biometrics (2008) 0.93

Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer (2011) 0.93

Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion. Eur Urol (2001) 0.92

Protein phosphorylation in intact cultured sycamore (Acer pseudoplatanus) cells and its response to fusicoccin. Biochem J (1986) 0.92

Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression. Br J Cancer (2011) 0.92

The oxidation produced by hydrogen peroxide on Ca-ATP-G-actin. Protein Sci (2000) 0.90

Different metabolizing ability of thiol reactants in human and rat blood: biochemical and pharmacological implications. J Biol Chem (2000) 0.90

H2O2-treated actin: assembly and polymer interactions with cross-linking proteins. Biophys J (1995) 0.90

Molecular pathways involved in the early and late damage induced by testis ischemia: evidence for a rational pharmacological modulation. Curr Med Chem (2012) 0.90

Effect of respiratory rate on the relationships between RR interval and systolic blood pressure fluctuations: a frequency-dependent phenomenon. Cardiovasc Res (1998) 0.89

Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder. Eur Urol (2000) 0.89

Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free-beta hCG. Prospective and retrospective results. Minerva Ginecol (1996) 0.89

Reconfiguration of the severely fibrotic penis with a penile implant. J Urol (2001) 0.89

Pathophysiology of reno-ureteral colic. Urol Int (2004) 0.88

Prognostic significance of the evaluation of bronchoalveolar lavage cell populations in patients with HIV-1 infection and pulmonary involvement. Chest (1991) 0.88

Combined renal and pyelic fusion with crossed ectopia of single ureter. Urology (1986) 0.88

Microtubule associated protein MAP1A is an actin-binding and crosslinking protein. Cell Motil Cytoskeleton (1994) 0.88

White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study. Cancer Epidemiol Biomarkers Prev (1998) 0.88

Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. J Urol (2010) 0.88

Partial left lateral segment transplant from a living donor. Liver Transpl (2000) 0.88

A quarter of men with idiopathic oligo-azoospermia display chromosomal abnormalities and microdeletions of different types in interval 6 of Yq11. Hum Genet (1998) 0.87

Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study. Andrologia (2013) 0.87

Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews. Am J Hum Genet (2001) 0.87

A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis (2003) 0.87

Role of US in acute scrotal pain. World J Urol (2011) 0.87

Characterization of the chlorpropamide-alcohol-flush in patients with type 1 and type 2 diabetes. Acta Diabetol Lat (1983) 0.87

The ablative effect of quarter dose bacillus Calmette-Guerin on a papillary marker lesion of the bladder. J Urol (2001) 0.87

The role of hypoxia in erectile dysfunction mechanisms. Int J Impot Res (2007) 0.87

cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers. J Cell Physiol (2005) 0.87

A new splicing site mutation of the ABCB4 gene in intrahepatic cholestasis of pregnancy with raised serum gamma-GT. Dig Liver Dis (2009) 0.87

Ureterouterine fistula as a complication of cesarean section. J Urol (1994) 0.87

The steatocrit. J Pediatr Gastroenterol Nutr (1989) 0.86

Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia. Curr Med Chem (2013) 0.86

Epidemiology of urogenital infections caused by Chlamydia trachomatis and outline of characteristic features of patients at risk. J Med Microbiol (1994) 0.86

Long-term results of surgical management of pulmonary metastases from renal cell carcinoma. Thorac Cardiovasc Surg (2006) 0.86

[Management, and prevention, of intravesical therapy complications]. Urologia (2010) 0.86

Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. J Urol (1996) 0.86

Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3. Neurology (2007) 0.86